KEVIN M. LALANDE

Insider Reports History

Location
Austin, TX
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by KEVIN M. LALANDE:

Company Role Class Num Shares Value Price $ Report Date Ownership
Molecular Templates, Inc. Director, 10%+ Owner Common Stock 406,486 $955,242 $2.35 02 Apr 2024 By Sante Health Ventures I, L.P.
Molecular Templates, Inc. Director, 10%+ Owner Pre-Funded Warrants (Right to Buy) 402,077 $944,479 $2.35 02 Apr 2024 By SHV MTEM SPV, LLC
Molecular Templates, Inc. Director, 10%+ Owner Common Stock 175,000 $411,250 $2.35 02 Apr 2024 By SHV MTEM SPV, LLC
Molecular Templates, Inc. Director, 10%+ Owner Common Stock 57,644 $135,463 $2.35 02 Apr 2024 By Sante Health Ventures I Annex Fund, L.P.
Molecular Templates, Inc. Director, 10%+ Owner Common Stock 14,800 $34,780 $2.35 02 Apr 2024 By SHVMS, LLC
Molecular Templates, Inc. Director, 10%+ Owner Common Stock 3,333 $7,833 $2.35 02 Apr 2024 By SHV Management Services, L.P.
LUMOS PHARMA, INC. Director Common Stock 0 $0 $1.89 12 Dec 2024 By Sante Health Ventures II, LP
LUMOS PHARMA, INC. Director Common Stock 0 $0 $1.89 12 Dec 2024 Direct
Molecular Templates, Inc. Director, 10%+ Owner Warrants (Right to Buy) 1,154,154 02 Apr 2024 By SHV MTEM SPV, LLC
Molecular Templates, Inc. Director, 10%+ Owner Stock Option (right to buy) 1,000 27 Sep 2024 Direct
LUMOS PHARMA, INC. Director Stock Option (Right to Buy) 0 12 Dec 2024 Direct

Insider Reports Filed by KEVIN M. LALANDE

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000112623424000115-lalande-kevin-m-2024-12-12 LUMOS PHARMA, INC. 12 Dec 2024 7 $0 4 Director 13 Dec 2024, 21:31
/report/000095017024110465-lalande-kevin-m-2024-09-27 Molecular Templates, Inc. 27 Sep 2024 1 $0 4 Director, 10%+ Owner 30 Sep 2024, 17:41
/report/000112623424000073-lalande-kevin-m-2024-06-05 LUMOS PHARMA, INC. 05 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:06
/report/000141588924010303-lalande-kevin-m-2024-04-02 Molecular Templates, Inc. 02 Apr 2024 3 +$1,499,998 4 Director, 10%+ Owner 04 Apr 2024, 16:57
/report/000117184323006567-lalande-kevin-m-2023-10-27 Molecular Templates, Inc. 27 Oct 2023 1 $0 4 Director, 10%+ Owner 31 Oct 2023, 18:45
/report/000112623423000070-lalande-kevin-m-2023-05-10 LUMOS PHARMA, INC. 10 May 2023 1 $0 4 Director 12 May 2023, 17:44
/report/000120919122038477-lalande-kevin-m-2022-06-13 Molecular Templates, Inc. 13 Jun 2022 3 +$198,380 4 Director, 10%+ Owner 21 Jun 2022, 17:12
/report/000089924322021140-lalande-kevin-m-2022-06-03 Molecular Templates, Inc. 03 Jun 2022 1 $0 4 Director, 10%+ Owner 06 Jun 2022, 07:30
/report/000112623422000054-lalande-kevin-m-2022-05-05 LUMOS PHARMA, INC. 05 May 2022 1 $0 4 Director 09 May 2022, 17:09
/report/000112623421000141-lalande-kevin-m-2021-09-08 LUMOS PHARMA, INC. 08 Sep 2021 1 +$112,116 4 Director 10 Sep 2021, 16:57
/report/000112623421000138-lalande-kevin-m-2021-09-02 LUMOS PHARMA, INC. 02 Sep 2021 3 +$273,783 4 Director 07 Sep 2021, 17:56
/report/000112623421000133-lalande-kevin-m-2021-08-30 LUMOS PHARMA, INC. 30 Aug 2021 3 +$204,811 4 Director 01 Sep 2021, 18:46
/report/000112623421000129-lalande-kevin-m-2021-08-25 LUMOS PHARMA, INC. 25 Aug 2021 3 +$261,790 4 Director 27 Aug 2021, 19:16
/report/000112623421000123-lalande-kevin-m-2021-08-20 LUMOS PHARMA, INC. 20 Aug 2021 3 +$775,660 4 Director 24 Aug 2021, 18:19
/report/000112623421000117-lalande-kevin-m-2021-08-17 LUMOS PHARMA, INC. 17 Aug 2021 3 +$556,426 4 Director 19 Aug 2021, 20:14
/report/000112623421000115-lalande-kevin-m-2021-08-12 LUMOS PHARMA, INC. 12 Aug 2021 3 +$724,392 4 Director 16 Aug 2021, 18:09
/report/000089924321022042-lalande-kevin-m-2021-06-03 Molecular Templates, Inc. 03 Jun 2021 1 $0 4 Director, 10%+ Owner 04 Jun 2021, 16:30
/report/000112623421000080-lalande-kevin-m-2021-05-20 LUMOS PHARMA, INC. 20 May 2021 2 $0 4 Director 24 May 2021, 18:36